📊 DH Key Takeaways
Is Definitive Healthcare Corp. (DH) a Good Investment?
Despite strong gross margins of 75.9% and positive free cash flow of $37.1M, Definitive Healthcare is unprofitable with significant operating losses (-$224.3M) and negative net income (-$138.9M), indicating operational inefficiency and value destruction. Revenue declined 4.2% YoY while losses persist, suggesting fundamental business model challenges that cash reserves and FCF generation cannot offset.
Definitive Healthcare shows a fundamentally mixed profile: strong gross margins and positive free cash flow indicate the core software model still has economic value, and liquidity appears adequate. However, declining revenue, deeply negative operating and net margins, and weak interest coverage point to a business that is not converting its gross profit into durable earnings. Until the company restores consistent top-line growth and materially improves operating leverage, the fundamentals remain weak.
Why Buy Definitive Healthcare Corp. Stock? DH Key Strengths
- Strong gross margin of 75.9% demonstrates pricing power and customer value in healthcare software
- Positive free cash flow of $37.1M with healthy 15.3% FCF margin despite operating losses
- Solid balance sheet with $163.6M cash and manageable debt-to-equity ratio of 0.44x provides financial stability
- High gross margin of 75.9% suggests attractive unit economics in the core software business
- Positive operating cash flow of $53.78M and free cash flow of $37.06M support near-term financial flexibility
- Solid liquidity and moderate leverage with a 1.64x current ratio, $163.63M cash, and 0.44x debt-to-equity
DH Stock Risks: Definitive Healthcare Corp. Investment Risks
- Severe operating losses of -$224.3M with -92.9% operating margin indicating fundamental unprofitability despite high gross margins
- Revenue decline of 4.2% YoY combined with deteriorating net losses represents declining business momentum and market traction
- Negative interest coverage of -19.9x cannot sustain debt service long-term; company burning cash operationally despite FCF mask
- Revenue declined 4.2% YoY, raising concern about demand durability and growth quality
- Operating margin of -92.9% shows severe cost structure or charge-related pressure that overwhelms gross profit
- Negative interest coverage and sizable net losses indicate weak earnings support for debt obligations
Key Metrics to Watch
- Revenue growth trajectory and return to positive growth
- Operating margin improvement path to profitability
- Operating cash flow sustainability as operating losses may eventually reverse FCF generation
- Revenue growth reacceleration and customer retention/expansion trends
- Operating margin improvement and sustained free cash flow conversion
Definitive Healthcare Corp. (DH) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Definitive Healthcare Corp. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
DH Profit Margin, ROE & Profitability Analysis
DH vs Technology Sector: How Definitive Healthcare Corp. Compares
How Definitive Healthcare Corp. compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Definitive Healthcare Corp. Stock Overvalued? DH Valuation Analysis 2026
Based on fundamental analysis, Definitive Healthcare Corp. shows some fundamental concerns relative to the Technology sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Definitive Healthcare Corp. Balance Sheet: DH Debt, Cash & Liquidity
DH Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Definitive Healthcare Corp.'s revenue has grown significantly by 52% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.79 indicates the company is currently unprofitable.
DH Revenue Growth, EPS Growth & YoY Performance
DH Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $60.0M | -$14.8M | $-0.14 |
| Q2 2025 | $60.8M | -$7.6M | $-0.07 |
| Q1 2025 | $59.2M | -$9.5M | $-0.08 |
| Q3 2024 | $62.7M | -$130.9M | $-1.12 |
| Q2 2024 | $61.0M | -$8.6M | $-0.08 |
| Q1 2024 | $59.2M | -$9.5M | $-0.08 |
| Q3 2023 | $57.4M | -$3.0M | $-0.03 |
| Q2 2023 | $54.5M | -$5.5M | $-0.06 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Definitive Healthcare Corp. Dividends, Buybacks & Capital Allocation
DH SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Definitive Healthcare Corp. (CIK: 0001861795)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DH
What is the AI rating for DH?
Definitive Healthcare Corp. (DH) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (SELL) with 80% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are DH's key strengths?
Claude: Strong gross margin of 75.9% demonstrates pricing power and customer value in healthcare software. Positive free cash flow of $37.1M with healthy 15.3% FCF margin despite operating losses. ChatGPT: High gross margin of 75.9% suggests attractive unit economics in the core software business. Positive operating cash flow of $53.78M and free cash flow of $37.06M support near-term financial flexibility.
What are the risks of investing in DH?
Claude: Severe operating losses of -$224.3M with -92.9% operating margin indicating fundamental unprofitability despite high gross margins. Revenue decline of 4.2% YoY combined with deteriorating net losses represents declining business momentum and market traction. ChatGPT: Revenue declined 4.2% YoY, raising concern about demand durability and growth quality. Operating margin of -92.9% shows severe cost structure or charge-related pressure that overwhelms gross profit.
What is DH's revenue and growth?
Definitive Healthcare Corp. reported revenue of $241.5M.
Does DH pay dividends?
Definitive Healthcare Corp. does not currently pay dividends.
Where can I find DH SEC filings?
Official SEC filings for Definitive Healthcare Corp. (CIK: 0001861795) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DH's EPS?
Definitive Healthcare Corp. has a diluted EPS of $-1.30.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is DH a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Definitive Healthcare Corp. has a SELL rating with 80% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is DH stock overvalued or undervalued?
Valuation metrics for DH: ROE of -36.7% (sector avg: 22%), net margin of -57.5% (sector avg: 18%). Compare these metrics with sector averages to assess valuation.
Should I buy DH stock in 2026?
Our dual AI analysis gives Definitive Healthcare Corp. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is DH's free cash flow?
Definitive Healthcare Corp.'s operating cash flow is $53.8M, with capital expenditures of $16.7M. FCF margin is 15.3%.
How does DH compare to other Technology stocks?
Vs Technology sector averages: Net margin -57.5% (avg: 18%), ROE -36.7% (avg: 22%), current ratio 1.64 (avg: 2.5).